Document is current
Any future updates will be listed below
-
Authors
Mabe, Nathaniel W. https://orcid.org/0000-0003-2675-652X
Perry, Jennifer A.
Malone, Clare F.
Stegmaier, Kimberly https://orcid.org/0000-0003-0218-7895
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35 CA283977, F32 CA261035, K99 CA279915, F32 CA243266)
EIF | Stand Up To Cancer (6143)
- License Information
-
More Information
Article History
Received: 6 May 2023
Accepted: 19 April 2024
First Online: 27 June 2024
Competing interests
: K.S. receives grant funding from the DFCI/Novartis Drug Discovery Program and KronosBio, is a member of the scientific advisory board of and has stock options with Auron Therapeutics, and has consulted for AstraZeneca. C.F.M. is a current employee and has stock options at InduPro. All other authors have no disclosures.
